Long-term results from a major federal study ease worries about the safety of a hormone-blocking drug that can lower a man's chances of developing prostate cancer. The drug cut prostate cancer risk by 30 per cent without raising the risk of dying of an aggressive form of the disease as earlier results hinted it might. The new work could prompt a fresh look at using the drug for cancer prevention. Read more here.
Study mentioned: Thompson Jr. IM, et al. Long-Term Survival of Participants in the Prostate Cancer Prevention Trial. N Engl J Med 2013; 369:603-610.
Connect to NCI Questions and Answers about PCPT here.
No comments:
Post a Comment